Pacific Alternative Asset Management Company (PAAMCO)’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-220,131	Closed	-$9.51M	–	53
2015 Q3	$9.51M	Buy	220,131 +87,820	+66%	+$3.71M	4.79%	4
2015 Q2	$5.59M	Sell	132,311 -101,760	-43%	-$4.29M	1.94%	13
2015 Q1	$9.08M	Buy	234,071 +115,292	+97%	+$4.44M	2.47%	12
2014 Q4	$4M	Buy	118,779 +32,102	+37%	+$1.13M	0.88%	25
2014 Q3	$3.04M	Buy	+86,677	New	+$2.97M	0.34%	73

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s WX Position: Q4 2015 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 220,131 shares — an estimated $9.51M sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in WX in Q3 2014 and held it in 5 quarters. The position peaked at $9.51M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Pacific Alternative Asset Management Company (PAAMCO) reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Pacific Alternative Asset Management Company (PAAMCO) sold 220,131 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $9.51M.
Pacific Alternative Asset Management Company (PAAMCO) first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2014 and held it in 5 quarters.
Pacific Alternative Asset Management Company (PAAMCO)'s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $9.51M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q4 2015, filed 11 Feb 2016.